Chongqing Lummy Pharmaceutical (300006.SZ) has obtained two drug registration certificates.
Leimai Pharmaceutical (300006.SZ) announces that the company has received approval and issuing of Nicolene tablets by the State Food and Drug Administration.
Chongqing Lummy Pharmaceutical (300006.SZ) announced that the company has received the "Drug Registration Certificate" for two drugs approved and issued by the National Medical Products Administration: Nicardipine tablets (specification: 5mg) and Ketorolac Tromethamine injection (specification: 1ml: 30mg). The announcement mentioned that Nicardipine tablets are used for the treatment of angina pectoris, while Ketorolac Tromethamine injection is suitable for short-term treatment of moderate to severe acute postoperative pain.
Related Articles
COWELL (01415) issued 360,000 shares due to the exercise of stock options.
C FIN SERVICES (00605) subsidiary granted a loan of RMB 14 million
GUSHENGTANG (02273) spent HKD 4.3762 million to buy back 130,000 shares on September 17th.
COWELL (01415) issued 360,000 shares due to the exercise of stock options.
C FIN SERVICES (00605) subsidiary granted a loan of RMB 14 million
GUSHENGTANG (02273) spent HKD 4.3762 million to buy back 130,000 shares on September 17th.
